RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 3.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $622,000 | +59.1% | 177,810 | -16.9% | 0.49% | +156.8% |
Q2 2020 | $391,000 | -24.8% | 214,040 | -35.8% | 0.19% | -40.0% |
Q1 2020 | $520,000 | +1825.9% | 333,389 | +2532.6% | 0.32% | +2361.5% |
Q4 2019 | $27,000 | -94.2% | 12,664 | -94.9% | 0.01% | -95.1% |
Q3 2019 | $469,000 | -21.2% | 250,693 | +10.0% | 0.27% | -18.8% |
Q2 2019 | $595,000 | +28.5% | 227,943 | +4.0% | 0.33% | +27.5% |
Q1 2019 | $463,000 | +131.5% | 219,143 | +150.7% | 0.26% | +70.9% |
Q4 2018 | $200,000 | +525.0% | 87,400 | +774.0% | 0.15% | +529.2% |
Q3 2018 | $32,000 | – | 10,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |